Zobrazeno 1 - 10
of 1 324
pro vyhledávání: '"Bastid, J"'
Autor:
Lemarchand C; ORPHELIA Pharma, 75005 Paris, France., Bienaymé H; ORPHELIA Pharma, 75005 Paris, France., Rieutord A; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Abbou S; Children and Adolescent Oncology Department, INSERM U1015, Paris-Saclay University, 94805 Villejuif, France., Annereau M; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94805 Villejuif, France., Bastid J; ORPHELIA Pharma, 75005 Paris, France.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2023 Nov 30; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 30.
Autor:
Ducray F; Service de Neuro-Oncologie, Hôpital Neurologique, Hospices Civils de Lyon, Centre de Recherche en Cancérologie UMR INSERM 1052 CNRS 5286, Université Claude Bernard Lyon 1, 69008 Lyon, France., Ramirez C; Services de Neurologie et D'oncologie Médicale, CHU et ICHUSE de Saint-Etienne, 42055 Saint-Etienne, France., Robert M; Institut de Cancérologie de l'Ouest, Medical Oncology, 44800 Saint Herblain, France., Fontanilles M; INSERM U1245 Unit, Cancer Centre Henri Becquerel, Université Rouen Normandie, 76038 Rouen, France.; Le Havre Hospital Group, 76083 Le Havre, France., Bronnimann C; CHU de Bordeaux, Service D'oncologie Médicale, Hôpital Saint André, 33075 Bordeaux, France., Chinot O; Aix-Marseille Université, Neuro-Oncology Department, APHM, CNRS, Institut de Neurophysiopathologie, CHU Timone, Service de Neuro-Oncologie, 13385 Marseille, France., Estrade F; Centre Eugène Marquis, 35042 Rennes, France., Durando X; INSERM U1240 IMoST, University of Clermont Auvergne, 63001 Clermont-Ferrand, France.; UMR 501, Clinical Investigation Centre, 63011 Clermont-Ferrand, France.; Clinical Research and Innovation Department, Centre Jean Perrin, 63011 Clermont-Ferrand, France.; Oncology Department, Centre Jean Perrin, 63011 Clermont-Ferrand, France., Cartalat S; Service de Neuro-Oncologie, Hôpital Neurologique, Hospices Civils de Lyon, Centre de Recherche en Cancérologie UMR INSERM 1052 CNRS 5286, Université Claude Bernard Lyon 1, 69008 Lyon, France., Bastid J; ORPHELIA Pharma, 75005 Paris, France., Bienayme H; ORPHELIA Pharma, 75005 Paris, France., Lemarchand C; ORPHELIA Pharma, 75005 Paris, France.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2023 Nov 24; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 24.
Publikováno v:
In Bulletin du Cancer January 2010 97(1):7-15
Autor:
Annereau M; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France.; EA 401: Matériaux et Santé, Université Paris-Sud, UFR Pharmacie, 92290 Châtenay-Malabry, France., Hinterlang M; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France., Bienayme H; Orphelia Pharma, 85 Boulevard Saint-Michel, 75005 Paris, France., Vassal G; Oncopaediatric Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France., Pinon A; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France., Schmitt M; Orphelia Pharma, 85 Boulevard Saint-Michel, 75005 Paris, France., Denis L; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France., Lemarchand C; Orphelia Pharma, 85 Boulevard Saint-Michel, 75005 Paris, France., Martin L; Orphelia Pharma, 85 Boulevard Saint-Michel, 75005 Paris, France., Lemare F; Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France., Abbou S; Oncopaediatric Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94800 Villejuif, France., Bastid J; Orphelia Pharma, 85 Boulevard Saint-Michel, 75005 Paris, France., Tortolano L; EA 401: Matériaux et Santé, Université Paris-Sud, UFR Pharmacie, 92290 Châtenay-Malabry, France.; Département de Pharmacie, Hôpital Universitaire Henri Mondor, AP-HP, F-94010 Créteil, France.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2022 Apr 29; Vol. 15 (5). Date of Electronic Publication: 2022 Apr 29.
Autor:
Gros L; Institut de recherche en cancérologie de Montpellier, Inserm U1194, université de Montpellier, institut régional du cancer de Montpellier, 34298 Montpellier, France., Paturel C; Innate Pharma, 117 avenue de Luminy, 13009 Marseille, France., Perrot I; Innate Pharma, 117 avenue de Luminy, 13009 Marseille, France., Bensussan A; OREGA Biotech, 69130 Ecully, France - Inserm UMRS 976, université Paris Diderot, Sorbonne Paris Cité, laboratoire immunologie, dermatologie et oncologie, 75475 Paris, France., Eliaou JF; Institut de recherche en cancérologie de Montpellier, Inserm U1194, université de Montpellier, institut régional du cancer de Montpellier, 34298 Montpellier, France - Département d'immunologie, centre hospitalier régional universitaire de Montpellier et faculté de médecine, université de Montpellier, 34295 Montpellier, France., Bastid J; OREGA Biotech, 69130 Ecully, France., Bonnefoy N; Institut de recherche en cancérologie de Montpellier, Inserm U1194, université de Montpellier, institut régional du cancer de Montpellier, 34298 Montpellier, France - OREGA Biotech, 69130 Ecully, France.
Publikováno v:
Medecine sciences : M/S [Med Sci (Paris)] 2020 Feb; Vol. 36 (2), pp. 112-115. Date of Electronic Publication: 2020 Mar 04.
Publikováno v:
Oncogene. 4/4/2013, Vol. 32 Issue 14, p1743-1751. 9p.
Autor:
Dzierżyński, Eliasz1 (AUTHOR) idziarzhynski@cozl.pl, Gawlik, Piotr J.1 (AUTHOR), Puźniak, Damian1 (AUTHOR), Flieger, Wojciech1,2,3 (AUTHOR), Jóźwik, Katarzyna4 (AUTHOR), Teresiński, Grzegorz5 (AUTHOR) grzegorzteresinski@umlub.pl, Forma, Alicja5 (AUTHOR), Wdowiak, Paulina6 (AUTHOR) paulina.wdowiak@kul.pl, Baj, Jacek7 (AUTHOR) jacek.baj@umlub.pl, Flieger, Jolanta8 (AUTHOR) jolanta.flieger@umlub.pl
Publikováno v:
Cancers. Nov2024, Vol. 16 Issue 21, p3703. 55p.
Autor:
Bastid J; OREGA Biotech, Ecully, France., Dejou C; OREGA Biotech, Ecully, France., Docquier A; OREGA Biotech, Ecully, France., Bonnefoy N; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut Régional du Cancer de Montpellier, Montpellier, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Apr 21; Vol. 11, pp. 718. Date of Electronic Publication: 2020 Apr 21 (Print Publication: 2020).
Publikováno v:
European Journal of Immunology, 43(7), 1925-1932
European Journal of Immunology, 43(7), 1925-32
European Journal of Immunology, 43(7), 1925-32
Regulatory T (Treg) cells can balance normal tissue homeostasis by limiting inflammatory tissue damage, e.g. during pathogen infection, but on the other hand can also limit protective immunity induced during natural infection or following vaccination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cda4e805bb10cc16cc39aa24a9bf3780
https://hdl.handle.net/1887/118909
https://hdl.handle.net/1887/118909
Autor:
Samaan, Sara F1 (AUTHOR), Taha, Sara I2 (AUTHOR) dr_sara_ib@med.asu.edu.eg, Mahmoud, Fatma A2 (AUTHOR), Elsaadawy, Yara3 (AUTHOR), Khalil, Salma A1 (AUTHOR), Gamal, Dalia M1 (AUTHOR)
Publikováno v:
Clinical Medicine Insights: Arthritis & Musculoskeletal Disorders. 9/17/2024, p1-9. 9p.